Candriam S.C.A.Candriam S.C.A.

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings860 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

3.2M$773.2M5.2%$177.01+32.32%
16 qtrssince 2019-Q1
Increased
62

APPLE INC

4.4M$572.1M3.9%$117.11+9.00%
16 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL A

4.1M$365.9M2.5%$95.45-8.25%
16 qtrssince 2019-Q1
Increased
53

MERCK & CO. INC.

3.2M$355.7M2.4%$67.03+51.06%
16 qtrssince 2019-Q1
Decreased
0

REGENERON PHARMACEUTICALS

382,968$276.3M1.9%$491.40+46.01%
16 qtrssince 2019-Q1
Decreased
0

UNITEDHEALTH GROUP INC

492,275$261M1.8%$357.66+40.33%
16 qtrssince 2019-Q1
Increased
49

AMGEN INC

979,786$257.3M1.7%$176.09+33.57%
16 qtrssince 2019-Q1
Increased
49

DANAHER CORP

944,363$250.6M1.7%$175.77+31.86%
16 qtrssince 2019-Q1
Increased
52

THERMO FISHER SCIENTIFIC INC

439,194$241.8M1.6%$409.99+33.13%
16 qtrssince 2019-Q1
Increased
50

PROCTER & GAMBLE CO/THE

1.5M$224.1M1.5%$111.92+22.81%
16 qtrssince 2019-Q1
Decreased
0

ELI LILLY & CO

537,869$196.8M1.3%$243.67+45.91%
16 qtrssince 2019-Q1
Decreased
0

VISA INC-CLASS A SHARES

788,290$163.8M1.1%$177.80+13.55%
16 qtrssince 2019-Q1
Increased
51

GILEAD SCIENCES INC

1.6M$140.3M0.9%$50.83+51.97%
16 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL C

1.6M$139.8M0.9%$96.54-8.77%
16 qtrssince 2019-Q1
Increased
45

VERTEX PHARMACEUTICALS INC

469,145$135.5M0.9%$203.97+41.58%
16 qtrssince 2019-Q1
Decreased
0

MASTERCARD INC - A

360,332$125.3M0.8%$288.06+18.43%
16 qtrssince 2019-Q1
Increased
44

DARLING INGREDIENTS INC

2M$124.6M0.8%$66.04-5.22%
8 qtrssince 2021-Q1
Increased
57

JOHNSON & JOHNSON

691,056$122.1M0.8%$139.36+15.71%
16 qtrssince 2019-Q1
Increased
56

BANK OF AMERICA CORP

3.6M$118.5M0.8%$30.61-1.07%
16 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

1.4M$117.7M0.8%$105.96-20.73%
16 qtrssince 2019-Q1
Increased
50
$14.8B
AUM
860
Positions
Q4 2022
Filing
Rating · 2.5
Quarterly Portfolio Change
+1%Q3'21$14.7B+7%Q4'21$15.7B-6%Q1'22$14.7B-17%Q2'22$12.1B+17%Q3'22$14.2B+4%Q4'22$14.8B
Activity profile
$ moved · Q4'22
New5%Increased50%Decreased38%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q4%1-4Q14%1-2Y10%2Y+73%

Candriam S.C.A. manages $14.8B across 860 positions as of Q4 2022. Top holdings: MSFT (5.2%), AAPL (3.9%), GOOGL (2.5%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q4 2022 Summary

Active quarter - 58 new positions, 67 exits, 279 increased. Top move: MSFT (INCREASED, conviction 62). Portfolio: $14.8B across 860 positions.

Top holdings by portfolio weight

Total AUM$15B
MSFT5.22%
AAPL3.86%
GOOGL2.47%
MRK2.40%
REGN1.86%
UNH1.76%
AMGN1.74%
DHR1.69%
TMO1.63%
PG1.51%
Other1.33%

Portfolio allocation by GICS sector

Sectors11
Healthcare31.40%
Technology22.48%
Financial Services9.90%
Consumer Cyclical7.65%
Industrials7.54%
Consumer Defensive5.62%
Communication Services5.48%
Unknown3.78%
Real Estate2.12%
Basic Materials1.62%
Other2.41%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record63
Conviction42
Concentration49
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AEMAEMAGNICO EAGLE MINES LTD
Q3 2024 Q2 2026+367,189 shares+$57.7M
8Q
AMZNAMZNAMAZON.COM INC
Q3 2024 Q2 2026+1.1M shares+$328M
8Q
CCCITIGROUP INC
Q3 2024 Q2 2026+275,890 shares+$52.2M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used